| Literature DB >> 33753937 |
Ani Nalbandian1, Kartik Sehgal2,3,4, Aakriti Gupta1,5,6, Mahesh V Madhavan1,5, Claire McGroder7, Jacob S Stevens8, Joshua R Cook9, Anna S Nordvig10, Daniel Shalev11, Tejasav S Sehrawat12, Neha Ahluwalia13, Behnood Bikdeli14,5,6,15, Donald Dietz16, Caroline Der-Nigoghossian17, Nadia Liyanage-Don18, Gregg F Rosner1, Elana J Bernstein19, Sumit Mohan8, Akinpelumi A Beckley20, David S Seres21, Toni K Choueiri22,23,14, Nir Uriel1, John C Ausiello9, Domenico Accili9, Daniel E Freedberg24, Matthew Baldwin7, Allan Schwartz1, Daniel Brodie7, Christine Kim Garcia7, Mitchell S V Elkind10,25, Jean M Connors14,26, John P Bilezikian9, Donald W Landry8, Elaine Y Wan27.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen responsible for the coronavirus disease 2019 (COVID-19) pandemic, which has resulted in global healthcare crises and strained health resources. As the population of patients recovering from COVID-19 grows, it is paramount to establish an understanding of the healthcare issues surrounding them. COVID-19 is now recognized as a multi-organ disease with a broad spectrum of manifestations. Similarly to post-acute viral syndromes described in survivors of other virulent coronavirus epidemics, there are increasing reports of persistent and prolonged effects after acute COVID-19. Patient advocacy groups, many members of which identify themselves as long haulers, have helped contribute to the recognition of post-acute COVID-19, a syndrome characterized by persistent symptoms and/or delayed or long-term complications beyond 4 weeks from the onset of symptoms. Here, we provide a comprehensive review of the current literature on post-acute COVID-19, its pathophysiology and its organ-specific sequelae. Finally, we discuss relevant considerations for the multidisciplinary care of COVID-19 survivors and propose a framework for the identification of those at high risk for post-acute COVID-19 and their coordinated management through dedicated COVID-19 clinics.Entities:
Mesh:
Year: 2021 PMID: 33753937 PMCID: PMC8893149 DOI: 10.1038/s41591-021-01283-z
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440